ASCO 2011 highlights
16 Jun 2011
ASCO 2011 highlights
Heterogeneity of tumours influences treatment
Risks of radiation treatment
Important factors influencing the treatment of head and neck cancer
Reducing global cancer mortality
Public-private partnerships in personalised medicine
Blood test for lung cancer in never-smokers
Oncoproteins and genes involved in the chromosomal translocations of APL
The Cancer Genome Atlas (TCGA)
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
New target identified for squamous cell lung cancer
Biomarker target for lung cancer chemoprevention